Diagnostic accuracy of OCT angiography for macular neovascularization in central serous chorioretinopathy: A systematic review and meta-analysis.
central serous chorioretinopathy
choroidal neovascularization
diagnostic accuracy
macular neovascularization
meta‐analysis
optical coherence tomography angiography
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
25
02
2024
accepted:
01
07
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
aheadofprint
Résumé
Identifying macular neovascularization (MNV) in eyes with central serous chorioretinopathy (CSC) has important implications for its management. Optical coherence tomography angiography (OCTA) is increasingly used for this purpose. Here, we systematically reviewed the literature and conducted meta-analysis to determine the diagnostic accuracy of OCTA for detecting MNV in eyes with CSC. We systematically searched the literature in 12 databases for relevant studies from database inception until 18 November 2023. Eligible studies had eyes with CSC with MNV and CSC without MNV. Index test was OCTA. Reference test was retinal dye angiography. Study selection and data extraction were performed in duplicate, and study was evaluated using the Quality Assessment of Diagnostic Accuracy Studies 2. Our main outcome of interest was the sensitivity and specificity of OCTA for detecting MNV in CSC. Pooled diagnostic test accuracy estimates were computed using MetaDTA. Of 177 records screened, seven fulfilled the eligibility criteria for our study. These studies summarized data from a total of 1061 eyes. Summary estimate sensitivity and specificity to diagnose MNV in eyes with CSC using OCTA was 92.9% (95% CI: 81.7%-97.5%) and 99.4% (95% CI: 84.1%-100.0%), respectively. The main source of bias across studies was the reference standard, as four studies used multimodal imaging including OCTA for the reference standard. OCTA alone is excellent for detecting MNV in CSC compared to retinal dye angiography or multimodal imaging. Using OCTA first before considering retinal dye angiography could potentially save an important number of retinal dye angiographies.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Berkowitz, S.T., Lam, S., Sternberg, P., Jr., Patel, S.N. & Finn, A.P. (2023) Time‐driven activity‐based costing analysis of fluorescein angiography. Ophthalmology Retina, 7, 804–810.
Bloch, S.B., Lund‐Andersen, H., Sander, B. & Larsen, M. (2013) Subfoveal fibrosis in eyes with neovascular age‐related macular degeneration treated with intravitreal ranibizumab. American Journal of Ophthalmology, 156, 116–124.e1.
Bonini Filho, M.A., de Carlo, T.E., Ferrara, D., Adhi, M., Baumal, C.R., Witkin, A.J. et al. (2015) Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography. JAMA Ophthalmology, 133, 899–906.
Borrelli, E., Battista, M., Gelormini, F., Sacconi, R., Querques, L., Vella, G. et al. (2020) Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease. Scientific Reports, 10, 20344.
Borrelli, E., Battista, M., Sacconi, R., Gelormini, F., Querques, L., Grosso, D. et al. (2021) OCT risk factors for 3‐year development of macular complications in eyes with "resolved" chronic central serous chorioretinopathy. American Journal of Ophthalmology, 223, 129–139.
Borrelli, E., Viganò, C., Battista, M., Sacconi, R., Senni, C., Querques, L. et al. (2023) Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 1267–1273.
Bousquet, E., Bonnin, S., Mrejen, S., Krivosic, V., Tadayoni, R. & Gaudric, A. (2018) Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy. Retina, 38, 629–638.
Breazzano, M.P., Fernández‐Avellaneda, P. & Freund, K.B. (2019) Swept‐source optical coherence tomography angiography of retinal arterial macroaneurysm with overlying hemorrhage. JAMA Ophthalmology, 137, e190247.
Breukink, M.B., Dingemans, A.J., den Hollander, A.I., Keunen, J.E., MacLaren, R.E., Fauser, S. et al. (2016) Chronic central serous chorioretinopathy: long‐term follow‐up and vision‐related quality of life. Clinical Ophthalmology, 11, 39–46.
Brinks, J., van Dijk, E.H.C., Meijer, O.C., Schlingemann, R.O. & Boon, C.J.F. (2022) Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. Acta Ophthalmologica, 100, 946–959.
Carnevali, A., Capuano, V., Sacconi, R., Querques, L., Marchese, A., Rabiolo, A. et al. (2017) OCT angiography of treatment‐Naïve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmology Retina, 1, 328–332.
Chen, C.X., Liu, M.L., Cao, K., Yusufu, M. & Wang, J.D. (2021) Diagnostic value of optical coherence tomography angiography for choroidal neovascularization in age‐related macular degeneration: a systematic review and meta‐analysis. Ophthalmic Research, 64, 704–712.
Cheung, C.M.G., Lee, W.K., Koizumi, H., Dansingani, K., Lai, T.Y.Y. & Freund, K.B. (2019) Pachychoroid disease. Eye (London, England), 33, 14–33.
Deeks, J.J., Bossuyt, P.M., Leeflang, M.M. & Takwoingi, Y. (Eds.). (2023) Cochrane handbook for systematic reviews of diagnostic test accuracy. Version 2.0 (updated July 2023). Cochrane. Available from: https://training.cochrane.org/handbook‐diagnostic‐test‐accuracy/current [Accessed 31st January 2024].
Demirel, S., Güran Beğar, P., Yanık, Ö., Batıoğlu, F. & Özmert, E. (2022) Visualization of type‐1 macular neovascularization secondary to pachychoroid spectrum diseases: a comparative study for sensitivity and specificity of indocyanine green angiography and optical coherence tomography angiography. Diagnostics (Basel), 12, 1368.
Demirel, S., Yanık, Ö., Nalcı, H., Batıoğlu, F. & Özmert, E. (2017) The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefe's Archive for Clinical and Experimental Ophthalmology, 255, 2317–2324.
Feenstra, H.M.A., van Dijk, E.H.C., Cheung, C.M.G., Ohno‐Matsui, K., Lai, T.Y.Y., Koizumi, H. et al. (2024) Central serous chorioretinopathy: an evidence‐based treatment guideline. Progress in Retinal and Eye Research, 101, 101236. Available from: https://doi.org/10.1016/j.preteyeres.2024.101236
Hagag, A.M., Rasheed, R., Chandra, S., Jeffery, G. & Sivaprasad, S. (2022) The diagnostic accuracy of double‐layer sign in detection of macular neovascularization secondary to central serous chorioretinopathy. American Journal of Ophthalmology, 236, 271–280.
Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J. et al. (Eds.). (2023) Cochrane handbook for systematic reviews of interventions. Version 6.4 (updated August 2023). Cochrane. Available from: www.training.cochrane.org/handbook [Accessed 31st January 2024].
Ho, M., Li, G., Mak, A., Ng, D., Iu, L. & Lai, F. (2021) Applications of multimodal imaging in central serous chorioretinopathy evaluation. Journal of Ophthalmology, 2021, 9929864.
Holtz, J.K., Larsson, J.M.E., Hansen, M.S., van Dijk, E.H.C. & Subhi, Y. (2022) Pachychoroid Spectrum diseases in patients with Cushing's syndrome: a systematic review with meta‐analyses. Journal of Clinical Medicine, 11, 4437.
Jain, M., Mohan, S. & van Dijk, E.H.C. (2022) Central serous chorioretinopathy: pathophysiology, systemic associations, and a novel etiological classification. Taiwan Journal of Ophthalmology, 12, 381–393.
Kido, A., Miyake, M., Tamura, H., Hiragi, S., Kimura, T., Ohtera, S. et al. (2021) Incidence of central serous chorioretinopathy (2011–2018): a nationwide population‐based cohort study of Japan. The British Journal of Ophthalmology, 106, 1748–1753.
Liu, C., Zhang, S., Deng, X., Chen, Y., Shen, L., Hu, L. et al. (2021) Comparison of intraocular cytokine levels of choroidal neovascularization secondary to different retinopathies. Frontiers in Medicine, 8, 783178.
Mao, J., Zhang, C., Zhang, S., Liu, C., Chen, N., Tao, J. et al. (2022) Predictors of anti‐VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes. Acta Ophthalmologica, 100, e1385–e1394.
McInnes, M.D.F., Moher, D., Thombs, B.D., McGrath, T.A., Bossuyt, P.M., Clifford, T. et al. (2018) Preferred reporting items for a systematic review and meta‐analysis of diagnostic test accuracy studies: the PRISMA‐DTA Statement. JAMA, 319, 388–396.
Mrejen, S., Balaratnasingam, C., Kaden, T.R., Bottini, A., Dansingani, K., Bhavsar, K.V. et al. (2019) Long‐term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology, 126, 576–588.
Muraleedharan, S. & Tripathy, K. (2023) Indocyanine green (ICG) angiography. In: StatPearls. Treasure Island, FL: StatPearls Publishing. August 25, 2023.
Ng, D.S., Ho, M., Chen, L.J., Yip, F.L., Teh, W.M., Zhou, L. et al. (2021) Optical coherence tomography angiography compared with multimodal imaging for diagnosing neovascular central serous chorioretinopathy. American Journal of Ophthalmology, 232, 70–82.
Patel, A., Cooper, N., Freeman, S. & Sutton, A. (2021) Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta‐analysis of diagnostic test accuracy data. Research Synthesis Methods, 12, 34–44.
Petri, A.S., Boysen, K., Cehofski, L.J., van Dijk, E.H.C., Dysli, C., Fuchs, J. et al. (2020) Intravitreal injections with vascular endothelial growth factor inhibitors: a practical approach. Ophthalmology and therapy, 9, 191–203.
Ruia, S. & Tripathy, K. (2023) Fluorescein angiography. In: StatPearls. Treasure Island, FL: StatPearls Publishing. August 25, 2023.
Savastano, M.C., Rispoli, M. & Lumbroso, B. (2021) The INCIDENCE of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina, 41, 302–308.
Spaide, R.F., Fisher, Y.L., Ngo, W.K. & Barbazetto, I. (2022) Regional scleral thickness AS a risk factor for central serous chorioretinopathy. Retina, 42, 1231–1237.
Stattin, M., Ahmed, D., Forster, J., Glittenberg, C., Herrmann, M., Krebs, I. et al. (2019) Detection of secondary choroidal neovascularization in chronic central serous chorioretinopathy by swept source‐optical coherence tomography angiography. Acta Ophthalmologica, 97, e135–e136.
Su, Y., Zhang, X., Gan, Y., Zeng, Y. & Wen, F. (2022) Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging. Photodiagnosis and Photodynamic Therapy, 40, 103126.
Subhi, Y., Bjerager, J., Boon, C.J.F. & van Dijk, E.H.C. (2022) Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data. Acta Ophthalmologica, 100, 89–95.
Subhi, Y., Windfeld‐Mathiasen, J., Horwitz, A. & Horwitz, H. (2023) Risk of central serous chorioretinopathy in male androgen abusers. Ophthalmology and therapy, 12, 1073–1080.
van Dijk, E.H.C., Feenstra, H.M.A., Bjerager, J., Grauslund, J., Boon, C.J.F. & Subhi, Y. (2023) Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta‐analyses. Acta Ophthalmologica, 101, 140–159.
van Dijk, E.H.C., van Rijssen, T.J., Subhi, Y. & Boon, C.J.F. (2020) Photodynamic therapy for chorioretinal diseases: a practical approach. Ophthalmology and therapy, 9, 329–342.
Whiting, P.F., Rutjes, A.W., Westwood, M.E., Mallett, S., Deeks, J.J., Reitsma, J.B. et al. (2011) QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine, 155, 529–536.
Zhang, L., Van Dijk, E.H.C., Borrelli, E., Fragiotta, S. & Breazzano, M.P. (2023) OCT and OCT angiography update: clinical application to age‐related macular degeneration, central serous chorioretinopathy, macular telangiectasia, and diabetic retinopathy. Diagnostics (Basel), 13, 232.